(Linagliptin 2.5mg')

Linagliptin
LINALIGLIP 2.5  is an oral medication that belongs to the class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It is primarily used for the management of type 2 diabetes mellitus.
Here are some key points about LINALIGLIP 2.5 :
Mechanism of action: LINALIGLIP 2.5  works by inhibiting the activity of the enzyme dipeptidyl peptidase-4 (DPP-4), which is responsible for the breakdown of incretin hormones such as glucagon-like peptide-1 (GLP-1). GLP-1 helps regulate blood sugar levels by stimulating insulin secretion and reducing the production of glucagon, a hormone that raises blood sugar levels. By inhibiting DPP-4, LINALIGLIP 2.5  increases the levels of GLP-1, leading to enhanced glucose control.
Indications: LINALIGLIP 2.5  is prescribed for the management of type 2 diabetes mellitus. It is used as an adjunct therapy, along with diet and exercise, to improve glycemic control. It is often used in combination with other antidiabetic medications such as metformin or sulfonylureas.
Dosage and administration: The recommended dosage of LINALIGLIP 2.5  is usually 5 mg taken orally once daily. It can be taken with or without food. The specific dosage may vary depending on individual factors, and it's important to follow the instructions provided by the healthcare provider.
Efficacy: LINALIGLIP 2.5  helps lower blood sugar levels by increasing insulin release from the pancreas and reducing the production of glucose by the liver. It is effective in improving glycemic control, particularly postprandial (after-meal) glucose levels.
Side effects: Common side effects of LINALIGLIP 2.5  may include upper respiratory tract infections, headache, nasopharyngitis (inflammation of the nose and throat), and gastrointestinal symptoms such as diarrhea and abdominal pain. Severe side effects are rare but may include pancreatitis (inflammation of the pancreas) and hypersensitivity reactions.
Precautions and considerations: LINALIGLIP 2.5 should be used with caution in individuals with severe kidney impairment, as the dosage may need adjustment. It is generally well-tolerated and does not commonly cause hypoglycemia (low blood sugar) when used alone. However, it may interact with other medications, so it's important to inform your healthcare provider about all the medications you are taking.
For further information please contact: 
info@sterispharma.com 
Order Now - https://www.sterisonline.com/product/linaliglip-2-5-134280